YD Bio Ltd - Ordinary Shares, par value of US$0.0001 per share (YDES)

CUSIP: G98301107

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Ordinary Shares, par value of US$0.0001 per share
Shares outstanding
70,522,983
Total 13F shares
141,580
Share change
-33,838
Total reported value
$1,725,859
Price per share
$12.19
Number of holders
10
Value change
-$698,640
Number of buys
5
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP G98301107?
CUSIP G98301107 identifies YDES - YD Bio Ltd - Ordinary Shares, par value of US$0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of YD Bio Ltd - Ordinary Shares, par value of US$0.0001 per share (YDES) as of Q4 2025

As of 31 Dec 2025, YD Bio Ltd - Ordinary Shares, par value of US$0.0001 per share (YDES) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 141,580 shares. The largest 10 holders included GEODE CAPITAL MANAGEMENT, LLC, Cerity Partners LLC, Cypress Capital Management LLC (WY), CITADEL ADVISORS LLC, UBS Group AG, WOLVERINE ASSET MANAGEMENT LLC, CITIGROUP INC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, and FMR LLC. This page lists 10 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.